ERBB2 and breast cancer: Intriguingly, analysis of the TCGA data showed that DPAGT1 expression was increased in multiple types of HER2-overexpressing human cancer (26), including breast cancer, gastric cancer, colorectal cancer, and uterine corpus endometrioid carcinoma.